Patients are at the center of all we do, and oncology experts drive our approach. We are passionate about advancing safe and effective treatments to transform the lives of patients with liver metastases and pancreatic solid tumors.
TriSalus is at the forefront of developing effective treatment options.
Our culture is built on the reality that every patient matters. Our drug development programs are driven by the desire to give liver metastases and pancreatic solid tumor patients effective treatment options while maintaining their quality of life. We are committed to transforming deadly diseases into treatable conditions.
Through our relationships with advocacy groups, key cancer treatment experts, medical centers, and leading oncology researchers, we are working to develop safe and effective treatments that provide real clinical benefit and improve patient lives.
We are committed to:
- Raising awareness and improve understanding of our target oncology indications and our multi-pronged approach investigating the treatment of liver metastases and pancreatic solid tumors
- Providing timely information for patients interested in clinical trials
- Providing informational and educational resources addressing various patient and family needs